Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) covers the period ending July 19, 2016. The document serves as a transaction notification regarding a Person Discharging Managerial Responsibilities (PDMR) rather than a periodic financial report.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The only financial data present relates to a specific securities transaction:
- Instrument: American Depositary Shares (ADSs)
- Transaction Price: $43.87
- Transaction Volume: 87.393 ADSs
Material Changes
The filing reports an increase in the notional interest in ADSs for Mr. N Hirons, SVP of Global Ethics & Compliance. This change resulted from the re-investment of dividends paid to shareholders on July 14, 2016, under the Company's 2009 Performance Share Plan. No other material changes to the company's financial position are disclosed in this document.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is strictly a regulatory notification of an insider transaction.
Investor Verification Points
- Verify the total holdings of Mr. N Hirons following this dividend reinvestment.
- Confirm the dividend payment date of July 14, 2016, aligns with the company's standard dividend schedule.
- Note that this filing contains no operational or financial performance data for the quarter or year.